ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Biotalys

Biotalys (BTLS)

3.12
0.02
(0.65%)
Cerrado 25 Diciembre 10:30AM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
3.12
Postura de Compra
3.08
Postura de Venta
3.15
Volume Operado de la Acción
22,030
3.10 Rango del Día 3.15
2.50 Rango de 52 semanas 5.00
Capitalización de Mercado [m]
Precio Anterior
3.10
Precio de Apertura
3.11
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
17,744
Acciones en circulación
32,095,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-4.88
Beneficio por acción (BPA)
-0.64
turnover
2.61M
Beneficio neto
-20.51M

Acerca de Biotalys

Sector
Crop Plntng,cultvtng,protect
Industria
Crop Plntng,cultvtng,protect
Sitio web
Sede
Ghent, East Flanders, Bel
Fundado
-
Biotalys is listed in the Crop Plntng,cultvtng,protect sector of the Euronext with ticker BTLS. The last closing price for Biotalys was 3.10 €. Over the last year, Biotalys shares have traded in a share price range of 2.50 € to 5.00 €.

Biotalys currently has 32,095,000 shares in issue. The market capitalisation of Biotalys is 99.49 € million. Biotalys has a price to earnings ratio (PE ratio) of -4.88.

BTLS Últimas noticias

Publication of transparency notifications

Publication of transparency notifications Article 14(1) of the Law of 2 May 2007 on the disclosure of large shareholders in issuers whose shares are admitted to trading on a regulated marketGhent...

Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer

Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer Company Expands Senior Leadership Team with Experienced Agriculture Executive to Drive Partnerships Ghent, BELGIUM, Oct...

Biotalys announces Closing of Private Placement

Biotalys announces Closing of Private Placement Information on the total number of voting rights and sharesGhent, BELGIUM, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Press Release Regulated information...

Biotalys Obtains Subscription Commitments for EUR 15 Million through a Private Placement of New Shares with New and Current Investors

Biotalys Obtains Subscription Commitments for EUR 15 Million through a Private Placement of New Shares with New and Current Investors Additional Funds to further Build the AGROBODY™ Platform and...

Biotalys Expands R&D Pipeline with New Biofungicide Program

Biotalys Expands R&D Pipeline with New Biofungicide Program BioFun-8 Will Focus on Combatting Alternaria, a Top Leaf Spot Fungus, in Fruits, Vegetables and Potato CropsGhent, Belgium, Oct...

Biotalys Granted Patents for EVOCA in Both Europe and the United States

Biotalys Granted Patents for EVOCA in Both Europe and the United States Company Builds Global Intellectual Property Safeguards for Its Crop Protection Pipeline Ghent, Belgium, Sept. 17, 2024...

Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands

Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands Ghent, Belgium, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext: BTLS) an...

Biotalys Reports Half-Year 2024 Financial Results and Business Highlights

Biotalys Reports Half-Year 2024 Financial Results and Business Highlights                                                         Press release – regulated information Continued progress in...

Biotalys Named Sustainable Crop Protection Company of the Year

Biotalys Named Sustainable Crop Protection Company of the Year AgTech Breakthrough Awards Recognize Biotalys for Its Biocontrol Innovations to Sustainably Protect Crops from Pests and...

Biotalys Notice of Half Year 2024 Results and Business Highlights

Biotalys Notice of Half Year 2024 Results and Business Highlights Results Webcast and Conference Call to take place on Thursday, 22 August 2024 at 15:00 CEST / 14:00 GMT / 09:00 AM ETGhent...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.01-0.3194888178913.133.153.04262043.08889384DE
40.041.29870129873.083.252.79214463.0265793DE
120.010.321543408363.113.442.79177443.11044042DE
260.3613.04347826092.763.442.62160983.05180888DE
52-1.64-34.45378151264.7652.5177553.30775719DE
156-4.14-57.02479338847.267.41.62125684.00221561DE
260-4.64-59.7938144337.767.981.62127224.43301606DE

BTLS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Biotalys?
El precio actual de las acciones de Biotalys es 3.12 €
¿Cuántas acciones de Biotalys están en circulación?
Biotalys tiene 32,095,000 acciones en circulación
¿Cuál es la capitalización de mercado de Biotalys?
La capitalización de mercado de Biotalys es EUR 99.49M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Biotalys?
Biotalys ha negociado en un rango de 2.50 € a 5.00 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Biotalys?
El ratio precio/beneficio de Biotalys es -4.88
¿Cuál es el ratio de efectivo a ventas de Biotalys?
El ratio de efectivo a ventas de Biotalys es 38.33
¿Cuál es la moneda de reporte de Biotalys?
Biotalys presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Biotalys?
El último ingresos anual de Biotalys es EUR 2.61M
¿Cuál es el último beneficio anual de Biotalys?
El último beneficio anual de Biotalys es EUR -20.51M
¿Cuál es la dirección registrada de Biotalys?
La dirección registrada de Biotalys es BUCHTENSTRAAT 11, SINT-DENIJS-WESTREM, GHENT, EAST FLANDERS, 9051
¿Cuál es la dirección del sitio web de Biotalys?
La dirección del sitio web de Biotalys es www.biotalys.com
¿En qué sector industrial opera Biotalys?
Biotalys opera en el sector CROP PLNTNG,CULTVTNG,PROTECT

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
EIFDSTour Eiffel DS
0.0432 €
(800.00%)
89.74k
SEQUASequana medical NV
2.76 €
(33.33%)
1.64M
ALEUPEuroplasma
0.0484 €
(28.38%)
6.54M
ALPAUPaulic Meunerie SA
1.43 €
(16.26%)
17.14k
GNROGeNeuro SA
0.081 €
(15.38%)
330.33k
MLSMLSmalto
0.0125 €
(-32.43%)
50
ALVIAVialife Sa
13.30 €
(-27.72%)
7
MLMADMade
9.25 €
(-15.91%)
255
ALALOAcheterLouerFR
0.23 €
(-14.81%)
3.92k
ALLPLLepermislibre SA
0.397 €
(-11.78%)
3.01k
ATOAtos SE
0.0023 €
(-4.17%)
396.59M
BCPBanco Comercial Portugues SA
0.451 €
(0.16%)
17.85M
LATLatecoere
0.0094 €
(3.30%)
9.13M
ALVERVergnet
0.0021 €
(-4.55%)
8.37M
ALEUPEuroplasma
0.0484 €
(28.38%)
6.54M
Golden Cross Golden Cross 1 minuto hace
$ILLR Strong To Close Out 2024
ILLR
Golden Cross Golden Cross 3 minutos hace
Good chance of it... Looking for ~$1
LITM
jay_tee jay_tee 3 minutos hace
Seamus Clause is running late....
RNVA
Duma Duma 3 minutos hace
Don't know where prices really ended Tues. It took SC forever to post numbers that matched CS and then CS had a footnote that the numbers may not be correct. Guess we will see tomorrow. The early close was a mess price wise.

But what a week we are having SPY and QQQ have covered almo
QQQ
pennylane67 pennylane67 4 minutos hace
Yes. Me also. But nothing.
PBYA
treasurevalley treasurevalley 7 minutos hace
Merry Christmas to all even to havnaDragon . Oh my poor Barney, Dragon now and havnag before you changed again. We have a fire going you know we always have ham and eggs and biscuits and gravy on Christmas morning son. Hope all is good under the bridge. Try and think positive this new year. Instead
DPLS
Seminole Red Seminole Red 12 minutos hace
added to sticky posts MB....
Trend22 Trend22 15 minutos hace
Merry Christmas to all the old and new DPLS’ers!!
DPLS
Trend22 Trend22 16 minutos hace
Merry Christmas to all!!
surfkast surfkast 17 minutos hace
I wonder if that clown Nick with the sign got fired from the NJ bank and the real estate company he worked for? Had to move out of state.
NHMD
Think1st Think1st 17 minutos hace
Yeah yeah wait 2 years to get your $15 bucks or so..

Fun post of year sadly
Whenever I hear ..lets sue the co ..let's get a lawyer. let's SLAM him / co with this or that.lets teach them a lesson lol 😆
I sadly laugh ,because I know, usually the victims get $10 -
JustJack JustJack 19 minutos hace
In my opinion this is a share selling scam selling billions of shares each year to keep the doors open because there are minimal sales of the crappy devices the penny stock CEO buys from China and resells. They are 150 million in debt and the CEO takes 4 million a year in compensation. 
AITX
mike_dotcom mike_dotcom 20 minutos hace
If keeping up with demand is the risk I'm good with that!
AVXL
chrismiss_everyday chrismiss_everyday 20 minutos hace
https://www.sec.gov/Archives/edgar/data/1314052/000161577416007701/s104371_ex99-1.htm

Prior to joining Anavex, he served as the Chief Financial Officer of Curis and ImmunoGen. In addition, at Aventis (now Sanofi), Dr. Missling served as head of financial planning on all aspects of fin
AVXL
surfkast surfkast 23 minutos hace
OTCM

Profile Data
SIC - Industry Classification
7372 - Prepackaged software
Incorporation Information
NV, US, 2004
Employees
3 as of 12/01/2023
Shell
No

https://www.otcmarkets.com/stock/SPZI/overview

SPZI
cfoofme cfoofme 26 minutos hace
Merry Christmas Dale from America , the land of the free (if you aren’t a crook),lol. Hope you enjoy your jailbird Christmas dinner 😝.
Seminole Red Seminole Red 26 minutos hace
According to NFL reporter Ian Rapoport, the Pittsburgh Steelers will not have the services of quarterback Justin Fields in today's game versus the Kansas City Chiefs. Fields suffered an abdominal injury two weeks ago and was inactive versus the Baltimore Ravens last week.

If Fields ca
surfkast surfkast 27 minutos hace
Can you tell us what meds you are on as you are delusional.
HMBL
ddls ddls 28 minutos hace
It's way too late for this BIELshit.

BIEL is finished, DONE, is that understood? 😎
BIEL
hnbadger1 hnbadger1 30 minutos hace
The shorts are getting desperate! This is there latest attempt-
Anavex Life Sciences Faces
Manufacturing Challenges Impacting Product Launch and Financial Stability
Anavex Life Sciences (AVXL) has disclosed a new risk, in the
Manufacturing category. Anavex Life Sciences f
AVXL
jammy32 jammy32 30 minutos hace
Just my opinion. When / if elite does buy the adderall back from MIKAH, it will be because the volume is drying up and moving to vyvance. So the question for me is would a neutral Elite CEO even consider the purchase. This whole MIkAH thing really bothers me as it’s obvious that Nasrat / MIKAH
ELTP

Su Consulta Reciente

Delayed Upgrade Clock